Literature DB >> 8928610

Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy.

F Umehara1, S Izumo, M Takeya, K Takahashi, E Sato, M Osame.   

Abstract

Leukocyte adhesion molecules to endothelium plays an important role in the pathogenesis of inflammatory diseases, including HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). To help define the role of adhesion molecules in HAM/TSP, we studied the expression of lymphocyte function-associated antigen-1 (LFA-1), Mac-1, very late antigen-4 (VLA-4), Sialyl Lewisx (SLex), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1) and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions of HAM/TSP. The results indicate that spinal cord lesions of HAM/TSP have greater VCAM-1 expression on endothelium compared with those of controls. Infiltrating mononuclear cells, especially perivascular lesions, expressed VLA-4. Although the expression of ICAM-1 in the spinal cords was not distinctive between HAM/TSP and controls, infiltrating mononuclear cells in the spinal cords of HAM/TSP strongly expressed LFA-1 and Mac-1. ELAM-1 was expressed on endothelium in the inactive-chronic lesions from three of five HAM/HAM/TSP, but was not detectable in the spinal cords of controls. SLex reactions was detectable on occasional perivascular cells in the spinal cord of HAM/TSP, but not in those controls. MCP-1 was detectable on perivascular infiltrating cells and vascular endothelium in active-chronic lesions. This study suggest that VLA-4/VCAM-1 interaction may play an important role for lymphocyte migration into the central nervous system (CNS) and MCP-1 may also be involved in inflammatory cell recruitment to the CNS in HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8928610     DOI: 10.1007/s004010050435

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).

Authors:  M Seki; J I Kadota; Y Higashiyama; K Iida; T Iwashita; E Sasaki; S Maesaki; K Tomono; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Authors:  J B Guerreiro; S B Santos; D J Morgan; A F Porto; A L Muniz; J L Ho; A L Teixeira; M M Teixeira; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 4.  Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).

Authors:  Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease.

Authors:  Tatsufumi Nakamura; Katsuya Satoh; Taku Fukuda; Ikuo Kinoshita; Yoshihiro Nishiura; Kunihiko Nagasato; Atsushi Yamauchi; Yasufumi Kataoka; Tadahiro Nakamura; Hitoshi Sasaki; Kenji Kumagai; Masami Niwa; Mitsuru Noguchi; Hideki Nakamura; Noriyuki Nishida; Atsushi Kawakami
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

Review 6.  Human T-cell lymphotropic virus type I and neurological diseases.

Authors:  Masahiro Nagai; Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

7.  Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.

Authors:  I A Romero; M C Prevost; E Perret; P Adamson; J Greenwood; P O Couraud; S Ozden
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues.

Authors:  M Seki; Y Higashiyama; A Mizokami; J Kadota; R Moriuchi; S Kohno; Y Suzuki; K Takahashi; T Gojobori; S Katamine
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

9.  Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  Norihiro Takenouchi; Yoshihisa Yamano; Koichiro Usuku; Mitsuhiro Osame; Shuji Izumo
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

10.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.